- World rank, all time
- #6,203 of 42,892
- Rank in United States
- #1,424 of 8,685
- Research works
- 125 ▲ 22% vs 2013–17
- Citations
- 11k 85.9 per fractional work
- Top-10% rate
- 34.4% record average 16.5%
- Open access
- 41% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 12.4×. Every wedge is a field page.
- Immunology and Microbiology 12.4×
- Pharmacology, Toxicology and Pharmaceutics 3.4×
- Biochemistry, Genetics and Molecular Biology 2.8×
- Medicine 2.5×
- Economics, Econometrics and Finance 1.7×
- Mathematics 1.5×
- Chemistry 1.1×
- Social Sciences 0.5×
- Engineering 0.5×
- Agricultural and Biological Sciences 0.2×
- Materials Science 0.1×
- Environmental Science 0.1×
Who are the top researchers at Dynavax Technologies (United States)?
Ranked on the composite score, Robert L. Coffman lead among researchers whose main affiliation is Dynavax Technologies (United States).
- 1 Robert L. Coffman United States · #21,466 worldwide 566 citations · 40 works
Which keywords describe research at Dynavax Technologies (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Epidemiology, Immune Response, Immunity, Innate Immunity, Toll-like Receptors, Cancer Immunotherapy and Pattern Recognition Receptors.
- Hepatitis C Virus
- Tumor Microenvironment
- Hepatitis E Virus
- Pregnancy
- Allergic Diseases
- Zoonotic Transmission
- Allergen-specific Immunotherapy
- Waste Management
- Hepatitis B Virus
- Hepatocellular Carcinoma
- Treatment
- Natural Killer Cells
- Vaccine
- Antiviral Therapy
- Dendritic Cells
- Cytokine-Mediated Link
- Pattern Recognition Receptors
- Toll-like Receptors
- Immunity
- Inflammation
- Epidemiology
- Immune Response
- Innate Immunity
- Cancer Immunotherapy
- Antigen Presentation
- Innate Antiviral Responses
- Tumor Antigen
- Liver Disease
- NK Cell Recognition
- Pathogenesis
- Asthma
- Chronic Hepatitis B
- Recycling
- Autoimmunity
- Pollen Allergy
- Genetic Diversity
- Eosinophils
- Chronic Infection
- Municipal Solid Waste
- Genetic Variation
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology23▲ 4.5×28 topics
- Inflammation20▲ 6.7×19 topics
- Immune Response14▲ 18×11 topics
- Immunity13▲ 31×6 topics
- Innate Immunity12▲ 28×5 topics
- Toll-like Receptors11▲ 54×3 topics
- Cancer Immunotherapy11▲ 64×3 topics
- Pattern Recognition Receptors11▲ 61×2 topics
- Antigen Presentation10▲ 83×2 topics
- Cytokine-Mediated Link10▲ 120×1 topic
- Innate Antiviral Responses10▲ 120×1 topic
- Dendritic Cells10▲ 71×1 topic
- Tumor Antigen10▲ 101×1 topic
- Antiviral Therapy10▲ 50×3 topics
- Liver Disease9▲ 54×2 topics
- Vaccine9▲ 18×9 topics
- NK Cell Recognition9▲ 68×1 topic
- Natural Killer Cells9▲ 68×1 topic
- Pathogenesis7▲ 11×12 topics
- Treatment7▲ 4.6×9 topics
- Asthma7▲ 45×2 topics
- Hepatocellular Carcinoma7▲ 25×2 topics
- Chronic Hepatitis B6▲ 96×1 topic
- Hepatitis B Virus6▲ 96×1 topic
- Recycling6▲ 18×3 topics
- Waste Management5▲ 16×2 topics
- Autoimmunity5▲ 18×4 topics
- Allergen-specific Immunotherapy4▲ 77×1 topic
- Pollen Allergy4▲ 77×1 topic
- Zoonotic Transmission4▲ 30×3 topics
- Genetic Diversity4▲ 5.7×2 topics
- Allergic Diseases3▲ 34×1 topic
- Eosinophils3▲ 34×1 topic
- Pregnancy3▲ 12×4 topics
- Chronic Infection3▲ 136×1 topic
- Hepatitis E Virus3▲ 136×1 topic
- Municipal Solid Waste3▲ 73×2 topics
- Tumor Microenvironment3▲ 7.3×2 topics
- Genetic Variation3▲ 8.0×2 topics
- Hepatitis C Virus3▲ 46×1 topic
Which research topics does Dynavax Technologies (United States) publish most on?
By volume in 2022–2025: Vaccine Coverage and Hesitancy, Influenza Virus Research Studies, Immune Response and Inflammation and Cancer therapeutics and mechanisms.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Vaccine Coverage and Hesitancy Health 1 works
- 2 Influenza Virus Research Studies Epidemiology 0 works
- 3 Immune Response and Inflammation Immunology 0 works
- 4 Cancer therapeutics and mechanisms Molecular Biology 0 works
- 5 Hepatitis B Virus Studies Epidemiology 0 works
- 6 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
- 7 Viral gastroenteritis research and epidemiology Infectious Diseases 0 works
- 8 Lung Cancer Research Studies Oncology 0 works
- 9 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
- 10 PARP inhibition in cancer therapy Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Dynavax Technologies (United States)'s research output changed?
Output in 2018–2022 was 22% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Berkeley
- University of California, Berkeley
- Lawrence Berkeley National Laboratory
- Neurobehavioral Systems
- Mathematical Sciences Research Institute
- Plant (United States)
- Department of Health Services
- Museum of Vertebrate Zoology
- International Computer Science Institute
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.